Target intelligence / Profile preview

Dietary anions

Molecular classification
Other
01

Overview

Dietary anions in the intestinal lumen represent a diverse group of negatively charged molecules, including phosphate, oxalate, and bile acids, that are either ingested or secreted into the gastrointestinal tract. These anions play critical roles in physiological processes such as bone mineralization, pH buffering, and the emulsification of dietary fats. However, their excessive accumulation or absorption is associated with significant pathologies, most notably hyperphosphatemia in patients with chronic kidney disease and the formation of calcium oxalate kidney stones. In pharmacology, these anions are considered therapeutic targets for non-absorbed sequestering agents, such as phosphate binders and bile acid sequestrants. These drugs work by ion exchange or physical binding to form insoluble complexes that cannot be absorbed across the intestinal epithelium, thereby facilitating their excretion in feces. This localized mechanism of action allows for the management of systemic mineral and lipid imbalances while minimizing the risks associated with systemic drug distribution (National Center for Biotechnology Information, https://www.ncbi.nlm.nih.gov/books/NBK544250/; StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK526095/).

Other names
Intestinal anionsLuminal anionsDietary phosphateDietary oxalateBile acids (intestinal)
02

Mechanism of action

Sequestration and formation of insoluble complexes within the gastrointestinal tract to prevent systemic absorption and promote fecal excretion.

03

Biological functions

Electrolyte balanceMineral homeostasisLipid digestionMetabolic precursor
04

Disease associations

HyperphosphatemiaHyperoxaluriaHypercholesterolemiaChronic kidney disease-mineral and bone disorder (CKD-MBD)Nephrolithiasis
05

Safety considerations

Gastrointestinal distress (constipation, bloating, nausea)Interference with absorption of fat-soluble vitamins (A, D, E, K)Drug-drug interactions (binding of co-administered medications)Potential for systemic accumulation of metal-based binders (e.g., Lanthanum)Metabolic acidosis (with certain resin-based binders)
06

Interacting drugs

Sevelamer

8 more in the full profile.

07

Biomarkers

Serum phosphate levelsUrinary oxalate excretionSerum LDL cholesterolParathyroid hormone (PTH) levels

Beyond the preview

Go deeper on Dietary anions.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dietary anions.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call